U.S. stock futures were lower this morning, with the Dow futures falling around 0.2% on Tuesday.

Shares of Travere Therapeutics Inc (NASDAQ:TVTX) fell sharply in pre-market trading after the company issued a corporate update and 2026 outlook.

Travere Therapeutics said it expects total U.S. net product sales for the fourth quarter to be $127 million and expects $410 million U.S. net product sales for 2025. The company said it will restart Phase 3 HARMONY study in the first quarter of 2026.

Travere Therapeutics shares dipped 28.2% to $24.50 in pre-market trading.

Here are some other stocks moving lower in pre-market trading.

• Lulu’s Fashion Lounge Holdings Inc (NASDAQ:LVLU) shares dipped 10.4% to $10.89 in pre-market trading. Lulu’s Fashion Lounge Holdings shares jumped 79% on Monday after Friedland Enterprises acquired a 5% stake in the company.
• Graf Global Corp (NYSE:GRAF) tumbled 7% to $10.00 in pre-market trading.
• Ready Capital Corp (NYSE:RC) fell 4.3% to $2.01 in pre-market trading.
• Baidu Inc (NASDAQ:BIDU) declined 3.9% to $146.40 in pre-market trading after gaining 6% on Monday.
• PDD Holdings Inc – ADR (NASDAQ:PDD) fell 3.8% to $114.22 in pre-market trading.
• Amrize AG (NYSE:AMRZ) dipped 3.7% to $55.51 in pre-market trading.
• DeFi Technologies Inc (NASDAQ:DEFT) declined 3.7% to $1.04 in pre-market trading.
• Kingsoft Cloud Holdings Ltd (NASDAQ:KC) fell 3.5% to $12.93 in pre-market trading after jumping 22% on Monday.
• Sony Group Corp (NYSE:SONY) fell 3.3% to $24.34 in pre-market trading.

Now Read This:

• Bank of America Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts

Photo via Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.